Perseus Proteomics Reports Significant Exercise of Warrant Options in June

TOKYO, Jun 24 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported significant exercise of warrant options during the period from June 1, June 24, 2026 through January 05, 2026.

A total of 3,900 warrants out of 36,800 issued warrants were exercised, representing a ratio of 10.60%. As of the end of May, there were 14,299 unexercised warrants, which decreased to 10,399 as of the latest report. Details of the warrant exercises during the month included: - On June 1, no shares were delivered or transferred, but 265 warrants were exercised. - From June 1 to June 19, no additional transactions occurred.

- On June 22, 40,000 shares were delivered, and 139 warrants were exercised. - On June 23, no shares were delivered or transferred, but 139 warrants remained unexercised. - On June 24, 350,000 shares were delivered, and 139 warrants were exercised, with a warrant price of ¥3,500 per share. As of the end of May, the outstanding share count was 16,999,600 shares, including 90 treasury shares.

For more detailed information on the issuance of these warrant options, refer to the previous announcement dated December 17, 2025 titled "Third-party allotment-based issuance of the 29th series of warrant options (with adjusted exercise price clause) and conclusion of warrant option repurchase agreement." This marks a notable activity in the company's capital structure adjustments within the reporting period.